Their clinical AD data analysis began with a GWAS on a clinical AD cohort in which nearly half of participants had non-European ancestry, the dataset from the National Institute on Aging Genetics of ...
What’s important is to continue the person, connecting with him or her and providing the best quality of life.
As a neurologist at the forefront of research into Alzheimer's disease, I have worked with people who have managed to stop ...
1d
Alzheimer's is a neurodegenerative disease - meaning that it causes someone to lose cognitive abilities over time.
With genetic testing, we know more than ever about this devastating disease—but genes are only one part of the story.
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.
Dementia is not a disease itself. It is caused by different underlying diseases that affect the brain. Alzheimer’s disease is the most common cause of dementia. Other types of dementia include ...
Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...
AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...
The Alzheimer’s Foundation of America is encouraging caregiver to follow the I.R.I.S.H. tip to help loved ones celebrate St.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback